Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Acute	O
Pulmonary	O
Embolus,	O
Pericardial	O
Effusion	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
Female	O
who	O
presents	O
with	O
progressive	O
dyspnea,	O
ultimately	O
found	O
with	O
pericardial	O
effusion	O
and	O
multiple	O
subsegmental	O
pulmonary	O
emboli.	O
The	O
patient	O
reports	O
at	O
baseline	O
she	O
is	O
very	O
active,	O
doing	O
vigorous	O
physical	O
activity	O
such	O
as	O
line	O
dancing	O
and	O
at	O
baseline	O
has	O
no	O
problem	O
accomplishing	O
these	O
activities.	O
She	O
reports	O
over	O
the	O
month	O
prior	O
to	O
admission	O
she	O
has	O
been	O
becoming	O
progressivel	O
short	O
of	O
breath	O
with	O
minimal	O
activity	O
and	O
even	O
sometimes	O
at	O
rest.	O
She	O
also	O
reports	O
some	O
mild	O
chest	O
pressure,	O
which	O
is	O
exertional	O
in	O
nature.	O
She	O
denies	O
chest	O
pain,	O
cough,	O
PND,	O
pedal	O
edema	O
or	O
orthopnea.	O
She	O
reports	O
the	O
pressure	O
can	O
radiate	O
to	O
her	O
back,	O
but	O
never	O
down	O
the	O
arm	O
or	O
to	O
the	O
jaw.	O
In	O
the	O
ED	O
she	O
was	O
initially	O
ruled	O
out	O
for	O
MI	O
with	O
serial	O
enzymes	O
and	O
her	O
EKG	O
was	O
somewhat	O
concerning	O
for	O
dynamic	O
changes,	O
which	O
have	O
since	O
normalized.	O
She	O
also	O
underwent	O
a	O
stress	O
test,	O
which	O
was	O
negative	O
with	O
a	O
poor	O
DWP.	O
She	O
also	O
underwent	O
a	O
CTA	O
scan	O
of	O
the	O
chest	O
which	O
was	O
notable	O
for	O
multple	O
subsegmental	O
PEs	O
and	O
a	O
small	O
pericardial	O
effusion	O
Past	O
Medical	O
History:	O
Benign	O
Hypertension	O
Hyperlipidemia	O
Cholelithiasis	O
s/p	O
cholecystectomy	O
Chronic	O
Anemia	O
Pulmonary	O
Nodules,	O
s/p	O
resection	O
at	O
___	O
___,	O
pt	O
states	O
benign	O
and	O
a	O
current	O
one	O
being	O
monitored	O
Hysterectomy	O
glucose	O
intolerance	O
Social	O
History:	O
___	O
Family	O
History:	O
Brother:	O
Lung	O
CA,	O
MI	O
Mother:	O
CVA	O
Father:	O
CVA	O
Physical	O
Exam:	O
ROS:	O
GEN:	O
-	O
fevers,	O
-	O
Chills,	O
-	O
Weight	B-Weight_loss
Loss	B-Weight_loss
EYES:	O
-	O
Photophobia,	B-Visual_impairment
-	O
Visual	B-Visual_impairment
Changes	B-Visual_impairment
HEENT:	O
-	O
Oral/Gum	O
bleeding	O
CARDIAC:	O
+	O
Chest	O
Pressur,	O
-	O
Chest	O
Pain,	O
-	O
Palpitations,	O
-	O
Edema	O
GI:	O
-	O
Nausea,	O
-	O
Vomitting,	O
-	O
Diarhea,	O
-	O
Abdominal	O
Pain,	O
-	O
Constipation,	B-Constipation
-	O
Hematochezia	B-Lower_gastrointestinal_haemorrhage
PULM:	O
+	O
Dyspnea,	O
-	O
Cough,	O
-	O
Hemoptysis	O
HEME:	B-Upper_gastrointestinal_haemorrhage
-	O
Bleeding,	B-Upper_gastrointestinal_haemorrhage
-	O
Lymphadenopathy	O
GU:	O
-	O
Dysuria,	O
-	O
hematuria,	O
-	O
Incontinence	B-Urinary_incontinence
SKIN:	O
-	O
Rash	O
ENDO:	O
-	O
Heat/Cold	O
Intolerance	O
MSK:	O
-	O
Myalgia,	O
-	O
Arthralgia,	O
-	O
Back	O
Pain	O
NEURO:	O
-	O
Numbness,	O
-	O
Weakness,	O
-	O
Vertigo,	O
-	O
Headache	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
=====================================	O
VSS:	O
97.6,	O
132/70,	O
64,	O
18,	O
95%	O
GEN:	O
NAD,	O
Obese	O
Pain:	O
___	O
HEENT:	O
EOMI,	O
MMM,	O
-	O
OP	O
Lesions	O
PUL:	O
Feint	O
basilar	O
crackles	O
COR:	O
RRR,	O
S1/S2,	O
___	O
SEM	O
RSB	O
ABD:	O
NT/ND,	O
+BS,	O
-	O
CVAT	O
EXT:	O
-	O
CCE	O
NEURO:	O
CAOx3,	B-Delirium
Non-Focal	O
Discharge	O
EXAM:	O
====================================	O
VSS,	O
Exam	O
remained	O
unchanged.	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
===========================	O
___	O
06:45AM	O
BLOOD	O
WBC-4.4	O
RBC-3.80*	O
Hgb-12.4	O
Hct-36.5	O
MCV-96	O
MCH-32.6*	O
MCHC-34.1	O
RDW-13.3	O
Plt	O
___	O
___	O
08:00PM	O
BLOOD	O
WBC-5.8#	O
RBC-3.68*	O
Hgb-12.2	O
Hct-35.0*	O
MCV-95	O
MCH-33.2*	O
MCHC-35.0	O
RDW-13.0	O
Plt	O
___	O
___	O
03:30PM	O
BLOOD	O
WBC-3.7*	O
RBC-3.57*	O
Hgb-11.8*	O
Hct-34.3*	O
MCV-96	O
MCH-33.1*	O
MCHC-34.5	O
RDW-12.9	O
Plt	O
___	O
___	O
08:00PM	O
BLOOD	O
Neuts-41.3*	O
Lymphs-47.9*	O
Monos-5.0	O
Eos-5.0*	O
Baso-0.8	O
___	O
03:30PM	O
BLOOD	O
Neuts-36.0*	O
Lymphs-53.7*	O
Monos-5.4	O
Eos-4.1*	O
Baso-0.8	O
___	O
03:30PM	O
BLOOD	O
___	O
PTT-29.0	O
___	O
___	O
06:45AM	O
BLOOD	O
Glucose-95	O
UreaN-16	O
Creat-1.0	O
Na-144	O
K-3.8	O
Cl-104	O
HCO3-29	O
AnGap-15	O
___	O
08:00PM	O
BLOOD	O
Glucose-110*	O
UreaN-20	O
Creat-1.1	O
Na-138	O
K-3.2*	O
Cl-100	O
HCO3-27	O
AnGap-14	O
___	O
03:30PM	O
BLOOD	O
Glucose-98	O
UreaN-17	O
Creat-0.9	O
Na-143	O
K-3.3	O
Cl-102	O
HCO3-27	O
AnGap-17	O
___	O
09:32PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
03:30PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
03:30PM	O
BLOOD	O
Calcium-9.4	O
Phos-3.1	O
Mg-2.3	O
Pertinent	O
Studies:	O
ECG	O
Study	O
Date	O
of	O
___	O
2:45:50	O
___	O
Sinus	O
bradycardia.	O
Left	O
atrial	O
abnormality.	O
QS	O
deflections	O
in	O
leads	O
V1-V2	O
raising	O
a	O
question	O
of	O
prior	O
anteroseptal	O
myocardial	O
infarction	O
or	O
lead	O
placement.	O
Diffuse	O
non-specific	O
ST-T	O
wave	O
changes.	O
No	O
previous	O
tracing	O
available	O
for	O
comparison.	O
TRACING	O
#1	O
Intervals	O
Axes	O
Rate	O
PR	O
QRS	O
QT/QTc	O
P	O
QRS	O
T	O
53	O
184	O
98	O
438/425	O
45	O
-20	O
77	O
ECG	O
Study	O
Date	O
of	O
___	O
9:40:04	O
___	O
Sinus	O
bradycardia	O
and	O
occasional	O
ventricular	O
ectopy.	O
The	O
axis	O
is	O
now	O
leftward.	O
Left	O
atrial	O
abnormality.	O
There	O
is	O
variation	O
in	O
precordial	O
lead	O
placement	O
as	O
compared	O
with	O
previous	O
tracing	O
of	O
___.	O
Non-specific	O
ST-T	O
wave	O
changes	O
persist.	O
Ventricular	O
ectopy	O
has	O
appeared.	O
Otherwise,	O
no	O
diagnostic	O
interim	O
change.	O
TRACING	O
#2	O
Intervals	O
Axes	O
Rate	O
PR	O
QRS	O
QT/QTc	O
P	O
QRS	O
T	O
54	O
___	O
21	O
-34	O
31	O
Imaging:	O
====================	O
CHEST	O
(PRE-OP	O
PA	O
&	O
LAT)	O
Study	O
Date	O
of	O
___	O
4:23	O
___	O
IMPRESSION:	O
Cardiomegaly	O
with	O
trace	O
bilateral	O
pleural	O
effusions.	O
No	O
evidence	O
of	O
pneumonia.	B-Lower_respiratory_tract_infection
Surgical	O
clips	O
within	O
left	O
upper	O
lobe.	O
Stress	O
Study	O
Date	O
of	O
___	O
IMPRESSION:	O
Non-anginal	O
type	O
symptoms	O
in	O
the	O
absence	O
of	O
ischemic	O
EKG	O
changes.	O
Exertional	O
dyspnea	O
at	O
low	O
workload.	O
Ectopy	O
as	O
noted.	O
TTE	O
(Complete)	O
Done	O
___	O
at	O
11:33:27	O
AM	O
Conclusions	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
The	O
right	O
atrium	O
is	O
moderately	O
dilated.	O
No	O
atrial	O
septal	O
defect	O
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
There	O
is	O
a	O
minimally	O
increased	O
gradient	O
consistent	O
with	O
minimal	O
aortic	O
valve	O
stenosis.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
impaired	O
relaxation.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
very	O
small	O
pericardial	O
effusion.	O
There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade.	O
CTA	O
CHEST	O
W&W/O	O
C&RECONS,	O
NON-CORONARY	O
Study	O
Date	O
of	O
___	O
10:56	O
AM	O
Preliminary	O
Report	O
IMPRESSION:	O
1.	O
Two	O
subsegmental	O
pulmonary	O
emboli	O
in	O
the	O
right	O
lung.	O
2.	O
Cardiomegaly	O
and	O
a	O
small	O
pericardial	O
effusion.	O
3.	O
Right	O
upper	O
lobe	O
8-mm	O
nodule	O
for	O
which	O
followup	O
CT	O
in	O
six	O
months,	O
or	O
three	O
months	O
if	O
that	O
patient	O
has	O
risk	O
factors,	O
is	O
recommended	O
to	O
document	O
stability.	O
4.	O
Hiatal	O
hernia.	O
Micro:	O
=================	O
None	O
Discharge	O
Labs:	O
==================	O
___	O
07:10AM	O
BLOOD	O
___	O
PTT-40.5*	O
___	O
Brief	O
Hospital	O
Course:	O
Mrs.	O
___	O
is	O
a	O
___	O
y/o	O
F	O
with	O
h/o	O
HTN,	O
HLD,	O
and	O
pulmonary	O
nodules	O
s/p	O
resection	O
in	O
___	O
who	O
presented	O
to	O
ED	O
with	O
increased	O
dyspnea	O
and	O
found	O
to	O
have	O
small	O
pericardial	O
effusion,	O
small	O
PEs,	O
and	O
8mm	O
RUL	O
long	O
nodule.	O
Active	O
Issues:	O
=========================	O
1.	O
Acute	O
Pulmonary	O
Emboli:	O
Patient	O
was	O
sent	O
to	O
the	O
ED	O
from	O
PCP	O
for	O
increasing	O
dyspnea.	O
Initially,	O
cardiac	O
sources	O
for	O
her	O
dyspnea	O
were	O
entertained	O
as	O
she	O
had	O
EKG	O
with	O
TWI	O
in	O
V4-V5	O
and	O
had	O
negative	O
cardiac	O
enzymes	O
x2.	O
She	O
underwent	O
a	O
stress	O
test	O
that	O
was	O
a	O
limited	O
study	O
secondary	O
to	O
dyspnea.	O
She	O
underwent	O
a	O
CTA	O
on	O
___	O
that	O
revealed	O
pulmonary	O
emboli	O
as	O
well	O
small	O
pericardial	O
effusion.	O
Initially,	O
there	O
was	O
concern	O
that	O
the	O
pericardial	O
effusion	O
could	O
be	O
hemorrhagic,	O
however	O
after	O
discussion	O
with	O
radiology,	O
the	O
houndsfield	O
units	O
are	O
not	O
consistent	O
with	O
blood.	O
The	O
etiology	O
of	O
her	O
PE	O
currently	O
is	O
unknown.	O
It	O
appears	O
to	O
be	O
an	O
unprovoked	O
PE,	O
thus	O
requiring	O
6	O
months	O
of	O
anticoagulation	O
as	O
patient	O
is	O
up	O
to	O
date	O
on	O
colonoscopy	O
and	O
mammaography,	O
but	O
cannot	O
rule	O
out	O
another	O
occult	O
malignancy	O
during	O
this	O
admission.	O
She	O
was	O
started	O
on	O
lovenox	O
as	O
a	O
bridge	O
to	O
coumadin.	O
2.	O
Pericardial	O
Effusion:	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
pericardial	O
effusion	O
on	O
her	O
CTA	O
scan.	O
At	O
that	O
time,	O
a	O
pulsus	O
was	O
measured	O
to	O
be	O
<10.	O
On	O
___	O
she	O
had	O
a	O
TTE	O
performed	O
that	O
did	O
not	O
show	O
tamponade	O
physiology	O
and	O
noted	O
to	O
have	O
EF>55%	O
with	O
mild	O
aortic	O
stenosis.	O
Chronic	O
Issues:	O
================================	O
3.	O
Anemia:	O
baseline	O
around	O
34-36	O
since	O
___.	O
Her	O
hematocrit	O
remained	O
stable	O
around	O
her	O
baseline	O
during	O
this	O
admission.	O
4.	O
Benign	O
Hypertension:	O
She	O
was	O
continued	O
on	O
her	O
home	O
___	O
and	O
amlodipine.	O
5.	O
Hyperlipidemia:	O
she	O
was	O
continued	O
on	O
her	O
home	O
Crestor.	O
Transitional	O
Issues:	O
=========================	O
#.	O
Right	O
middle	O
lobe	O
8-mm	O
nodule	O
for	O
which	O
followup	O
CT	O
in	O
six	O
months,	O
or	O
three	O
months	O
if	O
that	O
patient	O
has	O
risk	O
factors,	O
is	O
recommended	O
to	O
document	O
stability.	O
#.	O
Aortic	O
Stenosis:	O
aortic	O
valve	O
area	O
1.9cm2.	O
#.	O
Full	O
Code	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
HOLD	O
for	O
SBP	O
<	O
100	O
2.	O
Rosuvastatin	O
Calcium	O
2.5	O
mg	O
PO	O
DAILY	O
3.	O
Terazosin	O
6	O
mg	O
PO	O
HS	O
HOLD	O
for	O
SBP	O
<	O
100	O
4.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
HOLD	O
for	O
SBP	O
<	O
100	O
Discharge	O
Medications:	O
1.	O
Enoxaparin	O
Sodium	O
100	O
mg	O
SC	O
Q12H	O
RX	O
*enoxaparin	O
300	O
mg/3	O
mL	O
please	O
inject	O
___	O
every	O
twelve	O
(12)	O
hours	O
Disp	O
#*10	O
Vial	O
Refills:*0	O
2.	O
Amlodipine	O
10	O
mg	O
PO	O
DAILY	O
HOLD	O
for	O
SBP	O
<	O
100	O
3.	O
Hydrochlorothiazide	O
25	O
mg	O
PO	O
DAILY	O
HOLD	O
for	O
SBP	O
<	O
100	O
4.	O
Rosuvastatin	O
Calcium	O
2.5	O
mg	O
PO	O
DAILY	O
5.	O
Terazosin	O
6	O
mg	O
PO	O
HS	O
HOLD	O
for	O
SBP	O
<	O
100	O
6.	O
Warfarin	O
5	O
mg	O
PO	O
DAILY16	O
RX	O
*warfarin	O
[Coumadin]	O
1	O
mg	O
5	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*40	O
Tablet	O
Refills:*0	O
7.	O
Outpatient	O
Lab	O
Work	O
INR	O
check	O
on	O
___	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Pulmonary	O
Embolism	O
Secondary:	O
pericardial	O
effusion,	O
pulmonary	O
nodules	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
part	O
in	O
your	O
care	O
at	O
___	O
___.	O
You	O
came	O
to	O
us	O
with	O
shortness	O
of	O
breath	O
and	O
chest	O
discomfort,	O
and	O
we	O
found	O
that	O
you	O
have	O
a	O
blood	O
clot	O
in	O
the	O
lungs	O
called	O
a	O
pulmonary	O
embolism.	O
While	O
with	O
us,	O
we	O
started	O
you	O
on	O
medications	O
to	O
thin	O
the	O
blood	O
and	O
allow	O
your	O
body	O
to	O
reabsorb	O
the	O
clot.	O
The	O
enoxaparin	O
(also	O
known	O
as	O
lovenox)	O
is	O
to	O
be	O
given	O
twice	O
daily	O
by	O
injection,	O
and	O
the	O
warfarin	O
(also	O
known	O
as	O
coumadin)	O
is	O
to	O
be	O
taken	O
once	O
daily	O
by	O
mouth.	O
The	O
coumadin	O
medication	O
requires	O
close	O
monitoring	O
on	O
initiation	O
with	O
serial	O
blood	O
tests,	O
but	O
you	O
may	O
be	O
able	O
to	O
discontinue	O
the	O
lovenox	O
under	O
consultation	O
with	O
your	O
PCP	O
once	O
the	O
coumadin	O
dosing	O
is	O
adjusted.	O
Your	O
primary	O
care	O
physician	O
is	O
arranging	O
for	O
their	O
___	O
clinic	O
to	O
contact	O
you	O
and	O
initiate	O
the	O
close	O
monitoring	O
required.	O
Followup	O
Instructions:	O
___	O

